R&D News | pharmaphorum

News

Gilead taps Tentarix for cancer, inflammation projects

Gilead Sciences has put $66 million down to start a collaboration with San Diego start-up Tentarix Biotherapeutics to develop new therapeutics for cancer and inflammatory

News

Harmony buys cannabidiol firm Zynerba in $200m deal

Neuroscience specialist Harmony Biosciences has agreed to acquire Zynerba, adding its cannabidiol (CBD) gel product Zygel for Fragile X syndrome and other rare neuropsychi

News

Ultragenyx is latest biotech sued over HeLa cell use

Just days after settling with Thermo Fisher for an undisclosed sum, the family of Henrietta Lacks has filed a lawsuit against Ultragenyx, another US biotech that it accuse

Home

Sunbird, Glympse merge for earlier diagnosis of Alzheimer’s

Biotech Sunbird Bio has announced its completed merger with Glympse Bio, which it is hoped will accelerate development of the companies’ protein-based diagnostic technolog

News

Regeneron dials up in gene therapy with Decibel deal

Regeneron has agreed a $109 million deal to acquire Decibel Therapeutics and its early-stage gene therapy for a form of congenital deafness, several years after forming a

News

eureKING buys SCTbio to extend biomanufacturing push

Special purpose acquisition company (SPAC) eureKING has agreed a deal to buy SCTbio as part of a plan to build a contract manufacturing company specialising in biologic th

Gilead taps Tentarix for cancer, inflammation projects

Harmony buys cannabidiol firm Zynerba in $200m deal

Ultragenyx is latest biotech sued over HeLa cell use

Sunbird, Glympse merge for earlier diagnosis of Alzheimer’s

Regeneron dials up in gene therapy with Decibel deal

eureKING buys SCTbio to extend biomanufacturing push

FDA grants three priority vouchers to psychedelics

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks